We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.61%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.67B
AUM Growth
-$263M
Cap. Flow
-$103M
Cap. Flow %
-3.85%
Top 10 Hldgs %
36.14%
Holding
81
New
10
Increased
17
Reduced
15
Closed
13

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$74.9M
2
JNJ icon
Johnson & Johnson
JNJ
+$44.2M
3
BDX icon
Becton Dickinson
BDX
+$41.6M
4
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$30.5M
5
MOH icon
Molina Healthcare
MOH
+$22.7M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$124M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$46.3M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$41.5M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$33.6M
5
HCA icon
HCA Healthcare
HCA
+$29M

Sector Composition

Rank Sector Weight
1 Healthcare 92.79%
2 Financials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTE
76
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-264,293
Closed -$4.68M
MRTX
77
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-315,449
Closed -$46.3M
SGEN
78
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-268,527
Closed -$41.5M
ALNA
79
DELISTED
Allena Pharmaceuticals
ALNA
– –
-284,285
Closed -$168K
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q1 2022 Portfolio in Review

As of Q1 2022, PFM Health Sciences held 81 positions worth $2.67B, down 8.9% from $2.94B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

PFM Health Sciences withdrew a net $103M in Q1 2022, closing 13 positions and reducing 15 holdings. Its most notable exit was AbbVie, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier, followed by Financials.

Against the trend, PFM Health Sciences opened a new position in Jazz Pharmaceuticals worth $80.4M.

  • PFM Health Sciences's largest Q1 2022 buy was Jazz Pharmaceuticals: 516,406 shares worth $80.4M.
  • PFM Health Sciences added most to Johnson & Johnson in Q1 2022, an estimated $44.2M increase.
  • PFM Health Sciences's biggest Q1 2022 reduction was HCA Healthcare, cutting an estimated $29M.
  • PFM Health Sciences fully exited AbbVie in Q1 2022, selling an estimated $124M.
  • PFM Health Sciences's ten largest holdings make up 36% of its $2.67B portfolio in Q1 2022.
  • PFM Health Sciences opened 10 new positions and closed 13 in Q1 2022.
  • PFM Health Sciences's portfolio value fell 8.9% quarter-over-quarter to $2.67B.

Based on PFM Health Sciences's 13F filing for Q1 2022, filed 16 May 2022.